The Lancet  Volume 358, Number 9277     21 July 2001 

  Science and medicine

IOM reviews evidence on thimerosal link to autism 

Persistent concern about the safety of vaccinations prompted the US National
Academy of Sciences Institute of Medicine to convene an open public meeting
in Cambridge, Massachusetts, on July 16, to review the evidence for an
association between thimerosal, a mercury-containing preservative found in
multidose vaccine preparations, and neurodevelopmental outcomes, particularly
autism, the prevalence of which has apparently increased over the past
decade.

Thimerosal, also known as ethylmercury, has been used as a preservative since
1930, and is now hypothesised to carry similar risks as methylmercury, a
chemical that is known to be toxic in animals and human beings. In June,
1999, the American Academy of Pediatrics and the US Public Health Service,
acknowledging that mercury exposure from vaccinations given in the first 6
months of life exceeded maximum acceptable levels established in federal
guidelines, called for a halt to the manufacture of thimerosal-containing
vaccines. Although no longer routinely given in the USA (European and UK
regulators have also recommended phasing out their use), they are still the
norm in many other parts of the world, especially in developing countries.
Neal Halsey (Johns Hopkins University, Baltimore, Maryland, USA) said that
all countries need to stop using these vaccines now, but single-use vaccines,
carrying added costs for storage, production, alternative preservatives, and
quality control measures, are prohibitively expensive for developing
countries.

The meeting was the third in a series of gatherings hosted by the IOM's
Immunization Safety Review Committee, an independent expert group established
by joint request of the Centers for Disease Control and Prevention and the
National Institutes of Health.

In its report, to be issued within 90 days of the meeting, the committee will
recommend public health responses for surveillance, research, and policy. It
will consider, in addition to the evidence for causality, the biological
plausibility of adverse events, and will explore the social and cultural
context of the issue.

Faith McLellan

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.